Major Pharmaceuticals Levothyroxine Sodium Tablets, USP Recall (October 2026)
Announced 2026-07-29 · FDA
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets, USP due to subpotent drug. Lot N02200 with expiration date 10/2026 was distributed nationwide in the USA. The recall is announced by the FDA.
| Brand | Major Pharmaceuticals |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61 |
| Reason | Subpotent Drug |
| Severity | moderate |
| Units affected | N/A |
| Distribution | Nationwide in the USA. |
| Agency | FDA |
| Recall / campaign no. | Lot #: N02200, Exp. Date 10/2026 |
WHAT YOU SHOULD DO
- Check if you have Lot N02200 tablets and note the expiration date 10/2026.
- Do not use any recalled tablets.
- Return the recalled tablets to your pharmacy or dispose of them according to local guidelines.
- Contact your healthcare provider for guidance on replacement therapy if needed.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.